Q4 2025 Holdings
Filed 2026-02-18 | 18 holdings | $57.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $31.2M | 524,786 | 54.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $15.2M | 73,745 | 26.2% |
| Biontech SE(BNTX) | COM | 09075V102 | $9.5M | 99,523 | 16.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.8M | 10,000 | 3.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $44.5K | 91,282 | 0.1% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $43.6K | 2,766,390 | 0.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | COM | G50871105 | $28.5K | 167,816 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $21.6K | 493,526 | 0.0% |
| Avadel Pharmaceuticals | COM | G29687103 | $18.4K | 855,860 | 0.0% |
| Sanofi(SNY) | COM | 80105N105 | $15.7K | 323,946 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $15.6K | 313,499 | 0.0% |
| Indivior PLC(INDV) | COM | G4766E116 | $12.2K | 339,532 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $10.4K | 1,180,388 | 0.0% |
| GSK PLC(GSK) | COM | 37733W204 | $4.7K | 96,729 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $3.4K | 149,634 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $3.1K | 4,000 | 0.0% |
| Alkermes PLC(ALKS) | COM | G01767105 | $3.0K | 107,822 | 0.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $665 | 100,000 | 0.0% |